Acute effect of proprotein convertase subtilisin/kexin type 9 inhibitor on oxidized low-density lipoprotein and lipid profile in patients at cardiovascular risk

In conclusion, PCSK9 inhibitors reduce ox-LDL levels in very high-risk ASCVD patients in a short time.PMID:37970546 | PMC:PMC10636578 | DOI:10.3164/jcbn.23-45

Source: Clinical Biochemistry - November 16, 2023 Category: Biochemistry Authors: Yiming Li Minni Sun Ran Li Min Dou Haozhe Dong Liqi Xue Guoju Sun Source Type: research